Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 58% ± 14% | |
adipocyte | 3 studies | 30% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 67% | 191.64 | 165 / 245 | 47% | 1.75 | 237 / 502 |
lung | 85% | 327.82 | 494 / 578 | 28% | 1.17 | 322 / 1155 |
muscle | 100% | 3244.87 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 3514.99 | 857 / 861 | 0% | 0 | 0 / 0 |
adipose | 77% | 235.76 | 924 / 1204 | 0% | 0 | 0 / 0 |
bladder | 67% | 167.43 | 14 / 21 | 9% | 0.61 | 47 / 504 |
breast | 47% | 151.76 | 215 / 459 | 26% | 3.40 | 292 / 1118 |
brain | 13% | 17.70 | 352 / 2642 | 59% | 2.25 | 415 / 705 |
skin | 53% | 121.09 | 966 / 1809 | 7% | 0.17 | 35 / 472 |
esophagus | 47% | 119.92 | 676 / 1445 | 10% | 0.32 | 18 / 183 |
ovary | 3% | 6.94 | 5 / 180 | 53% | 3.03 | 229 / 430 |
blood vessel | 48% | 146.42 | 638 / 1335 | 0% | 0 | 0 / 0 |
intestine | 25% | 46.32 | 246 / 966 | 2% | 0.48 | 8 / 527 |
uterus | 9% | 14.65 | 16 / 170 | 17% | 3.82 | 80 / 459 |
tonsil | 0% | 0 | 0 / 0 | 24% | 1.36 | 11 / 45 |
stomach | 19% | 51.05 | 68 / 359 | 5% | 0.15 | 15 / 286 |
adrenal gland | 4% | 6.12 | 11 / 258 | 11% | 0.75 | 26 / 230 |
kidney | 1% | 0.98 | 1 / 89 | 8% | 0.32 | 74 / 901 |
pancreas | 0% | 0.26 | 1 / 328 | 8% | 0.22 | 14 / 178 |
thymus | 1% | 5.59 | 9 / 653 | 6% | 0.34 | 34 / 605 |
liver | 0% | 0 | 0 / 226 | 1% | 0.05 | 4 / 406 |
peripheral blood | 1% | 1.77 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048738 | Biological process | cardiac muscle tissue development |
GO_0010467 | Biological process | gene expression |
GO_0060047 | Biological process | heart contraction |
GO_0007517 | Biological process | muscle organ development |
GO_0016012 | Cellular component | sarcoglycan complex |
GO_0042383 | Cellular component | sarcolemma |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | SGCG |
Protein name | Gamma-sarcoglycan (Gamma-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG) |
Synonyms | |
Description | FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. |
Accessions | Q13326 ENST00000218867.4 |